A review of clinical presentation and physiotherapy management of cerebral palsy patients in Esut teaching hospital, Enugu, Nigeria

Wilfred Okenwa, Anthony Edeh, Wilfred Okenwa, Anthony Edeh

Abstract

Background: Cerebral palsy affects the general neurological development of those involved. This usually culminates into various muscular deficits some of which are amenable to physiotherapy intervention and rehabilitation.

Method: A 6 year retrospective study was conducted to find out the clinical presentation and physiotherapy management of cerebral palsy patients in ESUT Teaching Hospital Enugu, Nigeria, between June 2009 and May, 2015.

Result: 146(30.2%) cases of cerebral palsy were noted out of 483 children seen within the period. There was male predominance n- 86(58.9%) and the commonest cause of cerebral palsy was birth asphyxia n- 56(38.4%).Several physiotherapy treatment modalities were applied, the common ones being neurodevelopment therapy, trans-cutaneous electric nerve stimulation, and passive and active exercise modules.Majority of the patients' accessed treatment less than 5 times n- 86(59%) and were lost to follow up subsequently. Slightly more than 10% of the patients accessed treatment consistently for 3 months.

Conclusion: High level of abandonment of treatment and lack of more modern physiotherapy modalities were noted. There is need to emphasize better health education of parents/guardians of the patients and improve social welfare benefits for the patients.

Keywords: Cerebral palsy; rehabilitation; social welfare.

© 2019 Okenwa et al.

References

    1. Rosenbaum P, Paneth N, Leviton A, et al. A report of the definition and classification of cerebral palsy. April 2006. (Erratum appears in Dev med child Neurol 2007, 49:n480) Dev Med Child Neurol. 2007;49(suppl 109):8–14.
    1. Ogunlesi T, Mojisola O, Folashade A, Bolanle F, Olusoga O, Adebiyi O. Socio- clinical issues in Cerebral palsy in Sagamu Nigeria. South African Journal of Child Health. 2008;2(3):120–124.
    1. “Cerebral Palsy: Hope through Research”. National Institute of Neurological Disorders and Stroke; 2013. Jul, [Feb. 18, 2018]. NIH Pub No. 13-159. Updated Feb. 12, 2018.
    1. Russman BS, Ashival S. Evaluation of the child with cerebral palsy. Seminars Pediatric Neurology. 11(1):47–51.
    1. Hutton Jl, Pharoah PO. Effects of Cognitive, Motor and sensory disabilities on survival cerebral palsy. Archives of Diseases in childhood. 2002;86(2):84–89.
    1. Suvanand Sahu, Kapoor SK, Reddaiah VF, Singh U, Sundaram KR. Risk factors for cerebral palsy. The Indian Journal of Pediatrics. 1997;64(5):677–685.
    1. Lagunju I, Oyinlade A, Famosaya A. Cerebral palsy in Nigerian children. Profile and impact on Educational opportunities. Developmental Medicine and child Neurology. 2016;58:44. doi: 10.1111/dmcn.61-13224.
    1. Izuora CI, Iloeje SO. A review of neurological disorders seen at the pediatrics neurologic clinic of the University of Nigeria Teaching Hospital Enugu. Ann trop Pediatrics. 1989;4:185–190.
    1. Bhattia M, Joseph B. Rehabilitation of cerebral palsy in a developing country: the need for comprehensive assessment. Pediatric Rehabil. 2000;4:83–86.
    1. Platt MJ, Lene C, Johnson A, et al. Trends in Cerebral palsy among infants of very low birth weight (<100g) or born prematurely (<32 weeks) in 16 European centers: a database study. Lancet. 2007;369:43–50. PubMed.
    1. Vincer MJ, Atlen Ac, Joseph Ks, Stinson Da, Scott H, Wood E. Increasing prevalence of cerebral palsy among very preterm infants: a population based study. Pediatrics. 2006;188:1621–1626.
    1. Burja S, Seme-Ciglenecki P, Gajsek-Marchetti M, Hajdirijak D, levanic A, Kodelic B. Epidemiological study of cerebral palsy in the Maribor region. Wein Klin Wochenschr. 2004;116(suppl 2):39–43.
    1. Robertson CMT, Watt MJ, Yasui Y. Changes in the prevalence of Cerebral palsy for children born very prematurely within a population — based program over 30 years. JAMA. 2007;297(24):2733–2740.
    1. Ayanniyi O, Abdulsalam KS. Profile of children with cerebral palsy attending out — Patient physiotherapy clinics in Southwest Nigeria. AJPARS. 2015;7(122):32–39. .
    1. Frank-Brigg AI, Alikor EAD. Sociocultural issues and causes of Cerebral palsy in Port Harcourt. Nigeria Journal of Paediatrics. 2011;38(3):115–119.
    1. Buljina A, Zubeevic S, Uzicanins Heljice. The role of risk factors in developmental diagnosis. Mediariski Archiv. 1999;53(3 supp1.2):5–8.
    1. El-Rifai MR, Ramia S, Moore V. Cerebral palsy in Riyadh Saudia: Etiological factors. Annals of Tropical Pediatrics. 1984;40:5–8.
    1. Peters GO, Adetola A, Fatudin MB. Review of pediatric neurological conditions seen in a physiotherapy department of a children's hospital in Ibadan, Nigeria. Afr J Biomed Res. 2008;11:281–284.
    1. Odding E, Roebroeck ME, Starn HJ. The epidemiology of Cerebral palsy, incidence, impairments and risk factors. Disabil Rehabil. 2006;28(4):183–191.
    1. Gangil A, Patwari AK, Areja S, Ahuja B, Anand VK. Feeding problems in children with Cerebral palsy. Indian Pediatric. 2001;38:846.
    1. Iloeje SO, Ejike-Orji C. Compliance by Cerebral palsy patients attending a child neurology service in a developing country: a preliminary report. West Afr J Med. 1993;12:1–5. PubMed.
    1. Novak Iona, Mcityry Sarah, Morgan Catherine, Campbell Lanie, Dark Leigha, Mortonetal Natalie. A systematic review of interventions for children with cerebral palsy: state of the evidence. Developmental medicine and child Neurology. 2013;55:885–910.
    1. Love SC, Novak 1, Kentish M, et al. Botulinum toxin assessment, intervention and after care for lower limb spasticity in children with cerebral palsy: International consensus statement. Eur J Neurol. 2010;17(suppl 2):9–37.
    1. Michaud LD. Prescribing therapy services for children with motor disabilities. Paediatrics. 2004;113(6):1836–1838.
    1. Koman L Andrew, Brashear Allison, Rosenfield Samuel, Chambers Henry, Russman Barry, Rang Mercer, et al. Botulinum Toxin A Neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: A multicenter, open label clinical trial. Paediatrics. 2001;108(05):1062–1071. doi: 10.1542/peds.108.5.1062.
    1. Moe PG, Seay AR. In: Neurological and muscular disorders. Current Diagnosis and Treatment. 15th Edition. Hay WN, Hayward AR, Levin MJ, Sondheider MJ, editors. 2001. pp. 697–698.
    1. Sanger Terence D. Movement disorders in cerebral palsy. J Pediatr Neurol. 2015;13:198–207.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner